für Versicherte der IK Innovationskasse
BSM (Bladder Status Monitoring)
Estimated delivery time
Shipping: up to 2 days
In stock
Product Details
BSM (Bladder Status Monitoring)
Registration no. DE/CA09/0930/IVD/015
In the early stages of bladder cancer, i.e. when the tumour is confined to the surface of the inner wall of the bladder, treatment is possible while preserving the bladder. After such bladder cancer treatment, the cancer may well recur in 70% of patients. To check this, 3-month follow-up examinations with cystoscopy are normally carried out. The protexam BSM test
avoids these unpleasant and risky cystoscopies.
- Take a urine sample at home - simple + discreet
- CE-compliant laboratory diagnostics
- High analysis accuracy
- Clinically tested
- Result within 2-3 working days of sample receipt
- VAT-exempt according to §4 No.14a UStG
BSM (Bladder Status Monitoring)
Display prices in:
EUR